Effect of Nebivolol on Blood Pressure in a Model of Hypertension Sensitive to Potentiation of Nitric Oxide Bioactivity.

Trial Profile

Effect of Nebivolol on Blood Pressure in a Model of Hypertension Sensitive to Potentiation of Nitric Oxide Bioactivity.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Dec 2016

At a glance

  • Drugs Nebivolol (Primary) ; Metoprolol tartrate; Sildenafil
  • Indications Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Apr 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 10 Nov 2014 Planned primary completion date changed from 1 Dec 2013 to 1 Jul 2014 according to ClinicalTrials. gov.
    • 24 Sep 2014 Planned End Date changed from 1 Dec 2013 to 1 Feb 2015 according to ClinicalTrials. gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top